Session Summary
The use of i2b2 for determining feasibility of clinical studies and clinical trials, focusing on the use of i2b2 in networks across the country, and novel approaches to allowing investigators to perform feasibility studies using i2b2-based client tools.
Presenter (4)
 Douglas MacFaddenChief Informatics Officer Harvard Catalyst |
Nich Wattanasin, MSTeam Lead Partners HealthCare |
Jack London
|
Kavi Wagholikar, PhDAssistant in Computer Science Massachusetts General Hospital |
Presentations
SHRINE UpdateReview of all the new features added to the SHRINE software View Presentation |
Using SHRINE and i2b2 for Feasibility StudiesNew features added to SHRINE and i2b2 Web Clients to help improve the workflow of identifying and extracting patient sets for clinical studies or trials. View Presentation |